Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Statistical Methods in Medical Research
|
March 6, 2020
MultiBaC: A strategy to remove batch effects between different omic data types
Manuel Ugidos, Sonia Tarazona, José M Prats-Montalbán, et al.
Bioinformatics (Oxford, England)
|
March 3, 2022
MultiBaC: an R package to remove batch effects in multi-omic experiments
Manuel Ugidos, María José Nueda, José M Prats-Montalbán, et al.
Frontiers in Genetics
|
December 18, 2018
Elucidating the Role of Chromatin State and Transcription Factors on the Regulation of the Yeast Metabolic Cycle: A Multi-Omic Integrative Approach
Víctor Sánchez-Gaya, Salvador Casaní-Galdón, Manuel Ugidos, et al.
Scientific Data
|
February 29, 2020
A multi-omics dataset of heat-shock response in the yeast RNA binding protein Mip6
Carme Nuño-Cabanes, Manuel Ugidos, Sonia Tarazona, et al.
American Journal of Hematology
|
October 2, 2023
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia
Maciej W Garbowski, Manuel Ugidos, Alberto Risueño, et al.
British Journal of Haematology
|
December 12, 2025
Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial
Maria Teresa Voso, Stéphane de Botton, Michael Pfeilstöcker, et al.
American Journal of Hematology
|
January 19, 2026
Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study
Rami S Komrokji, Sheida Hayati, Manuel Ugidos, et al.
American Journal of Hematology
|
January 19, 2023
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial
Andrew H Wei, Hartmut Döhner, Hamid Sayar, et al.
Blood
|
August 12, 2022
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
Hartmut Döhner, Andrew H Wei, Gail J Roboz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Statistical Methods in Medical Research
|
March 6, 2020
MultiBaC: A strategy to remove batch effects between different omic data types
Manuel Ugidos, Sonia Tarazona, José M Prats-Montalbán, et al.
Bioinformatics (Oxford, England)
|
March 3, 2022
MultiBaC: an R package to remove batch effects in multi-omic experiments
Manuel Ugidos, María José Nueda, José M Prats-Montalbán, et al.
Frontiers in Genetics
|
December 18, 2018
Elucidating the Role of Chromatin State and Transcription Factors on the Regulation of the Yeast Metabolic Cycle: A Multi-Omic Integrative Approach
Víctor Sánchez-Gaya, Salvador Casaní-Galdón, Manuel Ugidos, et al.
Scientific Data
|
February 29, 2020
A multi-omics dataset of heat-shock response in the yeast RNA binding protein Mip6
Carme Nuño-Cabanes, Manuel Ugidos, Sonia Tarazona, et al.
American Journal of Hematology
|
October 2, 2023
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia
Maciej W Garbowski, Manuel Ugidos, Alberto Risueño, et al.
British Journal of Haematology
|
December 12, 2025
Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial
Maria Teresa Voso, Stéphane de Botton, Michael Pfeilstöcker, et al.
American Journal of Hematology
|
January 19, 2026
Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study
Rami S Komrokji, Sheida Hayati, Manuel Ugidos, et al.
American Journal of Hematology
|
January 19, 2023
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial
Andrew H Wei, Hartmut Döhner, Hamid Sayar, et al.
Blood
|
August 12, 2022
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
Hartmut Döhner, Andrew H Wei, Gail J Roboz, et al.
Page
of 1